In these trials, 15 560 patients were assigned to rosiglitazone and 12 283 received placebo or an active comparator.

 
  • 在这些试验中,15560名受试者被分配到罗格列酮组,12283接受安慰剂或活性对比药物组。
今日热词
目录 附录 查词历史